Important News Update - COVID-19

Please note that we are in regular contact with the incredible research teams we fund globally and are offering our support as we know researchers are experiencing delays to their work. The full impact of COVID-19 on the research community will only become more apparent over the coming months.
Leaders of ongoing trials in the UK are implementing the advice from their institutions and governments (e.g. GOV.UK and MHRA.) about the best ways to support current trial participants given the closure of institutions, the need for social isolation and the inability of people living with Parkinson’s to attend clinical examinations.
Some of our new trials will not start recruitment until the health crisis is diminished.
Our grant review process involves the expertise of external experts to peer review applications and to attend Research Committee meetings and we are grateful to all those who contribute to this process. Please note, the COVID-19 crisis will impact on our calls for applications as we are dependent on the availability of these external experts to support the process. 


What research do we fund?

We fund laboratory or clinical research projects with potential to cure Parkinson’s. By “cure”, we mean disease-modifying therapy or therapies: to slow, stop or reverse underlying disease progression. In particular, we prioritise research which has potential to translate into the clinic within five years.

We do not fund research which is directed only to symptomatic relief.

Our full Research Strategy provides more information on the types of research we fund, our funding priorities and how we provide funding.

Funding to date

The projects we have funded to date are described here. In 2019, our Trustees granted funding to 26% of eligible new projects submitted to us.

Application process

In order to apply for funding for a research project, please read our Information for Applicants. This contains guidance on the process used for assessing projects for funding and the criteria used during assessment. It also contains links to the application forms to be completed and submitted to CPT by the next submission deadline.

If you have any questions regarding our funding scope, application process or subsequent work with successful applicants, please contact CPT using the details below. We recognise that there are many valuable areas of research into Parkinson’s that do not fall within the CPT’s funding scope.

Deadlines for applications

Grants applications are typically assessed four times per year, prior to scheduled Research Committee meetings when corresponding decisions will be taken. The next application deadlines are as follows:

  • 1st October 2020 (in advance of meeting 22nd October 2020)
  • 10th December 2020 (in advance of meeting 7th January 2021)
  • 2021 deadlines (and meeting dates) will be published as soon as possible.

Brief summary of next steps following application

If the proposed project falls within CPT’s scope for funding, it will be considered by the CPT Research Committee and considered for funding following the process outlined in our Information for Applicants.

This typically involves:

  • assessment by our Research Committee;
  • separate detailed written peer evaluation by at least two suitably qualified independent experts in the relevant field, for review by the Research Committee;
  • successful applications being recommended to the Board of Trustees, which makes final funding decisions;
  • all successful and unsuccessful applicants being notified of any decisions by the Chairman of the Research Committee and/or a suitable senior CPT representative.

Research Committee membership and conflict policy

The current members of our Research Committee are listed here.

All members have signed our Conflict of Interest Policy.

AMRC membership

CPT is a member of the Association of Medical Research Charities (AMRC) and follows AMRC requirements and guidance for best practice in research. AMRC charities are obliged to follow rigorous research evaluation (peer review) processes to ensure that only research of the highest quality is supported.

Contacting CPT

Potential applicants can reach CPT by emailing Deputy CEO Helen Matthews or calling: +44 20 7487 3892.


Important Notice November 2019:

AMRC Open Research, a new open access publishing platform from The Cure Parkinson's Trust (CPT) and 23 other medical research charities, is waiving the article processing charges for the next 25 articles submitted to the platform. This means that you can publish your CPT-funded research for free of charge. As a reminder, AMRC Open Research will publish any research funded by the participating charities, in a wide variety of article formats. This includes traditional research articles as well as output types that may be difficult to publish in traditional journals, including protocols, methods, case reports and negative results. We hope that you will take advantage of this and publish some of your CPT-funded research in AMRC Open Research.